Susan E. Stuber

1.2k total citations
30 papers, 362 citations indexed

About

Susan E. Stuber is a scholar working on Genetics, Hematology and Management of Technology and Innovation. According to data from OpenAlex, Susan E. Stuber has authored 30 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 27 papers in Hematology and 3 papers in Management of Technology and Innovation. Recurrent topics in Susan E. Stuber's work include Hemoglobinopathies and Related Disorders (30 papers), Iron Metabolism and Disorders (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Susan E. Stuber is often cited by papers focused on Hemoglobinopathies and Related Disorders (30 papers), Iron Metabolism and Disorders (26 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Susan E. Stuber collaborates with scholars based in United States, Canada and Kenya. Susan E. Stuber's co-authors include Russell E. Ware, Teresa Latham, Adam Lane, Banu Aygün, Léon Tshilolo, Peter Olupot‐Olupot, Thomas N. Williams, George Tomlinson, Brígida Santos and Patrick T. McGann and has published in prestigious journals such as New England Journal of Medicine, Blood and British Journal of Haematology.

In The Last Decade

Susan E. Stuber

25 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan E. Stuber United States	8	335	302	95	28	23	30	362
Maria Sitarou Cyprus	7	214 0.6×	172 0.6×	68 0.7×	7 0.3×	52 2.3×	15	261
Angela Allen United Kingdom	10	217 0.6×	207 0.7×	40 0.4×	10 0.4×	17 0.7×	28	290
Mahin Azimi United States	6	333 1.0×	283 0.9×	130 1.4×	6 0.2×	27 1.2×	11	357
Supriya Phanasgaonkar India	10	314 0.9×	283 0.9×	75 0.8×	5 0.2×	20 0.9×	20	350
Mariane de Montalembert France	7	227 0.7×	206 0.7×	51 0.5×	10 0.4×	11 0.5×	12	248
Herbert Opitz Switzerland	6	243 0.7×	239 0.8×	66 0.7×	2 0.1×	10 0.4×	6	278
Filippo Cassarà Italy	7	127 0.4×	114 0.4×	59 0.6×	2 0.1×	14 0.6×	21	164
Anna Metaxotou‐Mavrommati Greece	11	324 1.0×	270 0.9×	80 0.8×	2 0.1×	35 1.5×	13	346
Johara Hassan United States	4	190 0.6×	146 0.5×	76 0.8×		32 1.4×	10	222
C Ciaccio Italy	6	231 0.7×	181 0.6×	64 0.7×	4 0.1×	11 0.5×	8	341

Countries citing papers authored by Susan E. Stuber

Since Specialization

Citations

This map shows the geographic impact of Susan E. Stuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Stuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Stuber more than expected).

Fields of papers citing papers by Susan E. Stuber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Stuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Stuber. The network helps show where Susan E. Stuber may publish in the future.

Co-authorship network of co-authors of Susan E. Stuber

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Stuber. A scholar is included among the top collaborators of Susan E. Stuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Stuber. Susan E. Stuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Power‐Hays, Alexandra, Kathryn McElhinney, Thomas N. Williams, et al.. (2025). Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations. Blood Advances. 10(2). 418–427.

Nieves, Rosa M., Teresa Latham, Daniel Ramírez, et al.. (2025). Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial. Blood Advances. 9(8). 1791–1800. 3 indexed citations

Power‐Hays, Alexandra, George Tomlinson, Léon Tshilolo, et al.. (2024). Reducing transfusion utilization for children with sickle cell anemia in sub‐Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American Journal of Hematology. 99(4). 625–632. 6 indexed citations

Smart, Luke R., Susan E. Stuber, Kwesi Nyan Amissah-Arthur, et al.. (2024). Baseline characteristics of Ghanaian children and adults enrolled in PIVOT , a randomised clinical trial of hydroxyurea in HbSC disease in sub‐Saharan Africa. British Journal of Haematology. 205(6). 2470–2480.

Williams, Thomas N., Teresa Latham, George Tomlinson, et al.. (2024). Hydroxyurea Treatment Reduces Infection Rates in African Children with Sickle Cell Anemia. Blood. 144(Supplement 1). 545–545.

Power‐Hays, Alexandra, Kathryn McElhinney, Teresa Latham, et al.. (2024). Hydroxyurea Pharmacokinetics in Children with Sickle Cell Anemia: Comparison of Global Cohorts. Blood. 144(Supplement 1). 542–542. 1 indexed citations

Aygün, Banu, Adam Lane, Luke R. Smart, et al.. (2024). Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial. The Lancet Haematology. 11(6). e425–e435. 8 indexed citations

Power‐Hays, Alexandra, Ruth Namazzi, Charles Drago Kato, et al.. (2024). Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial. Acta Haematologica. 148(2). 1–12. 1 indexed citations

Backeljauw, Philippe, George Tomlinson, Luke R. Smart, et al.. (2024). Growth and Puberty in African Children with Sickle Cell Anemia Treated with Hydroxyurea. Blood. 144(Supplement 1). 544–544.

10.

Power‐Hays, Alexandra, Ruth Namazzi, Charles Drago Kato, et al.. (2024). Hydroxyurea Decreases Transfusion Utilization in Ugandan Children with Sickle Cell Anemia: Main Results from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial. Blood. 144(Supplement 1). 546–546. 1 indexed citations

11.

Smart, Luke R., Catherine Segbefia, Teresa Latham, et al.. (2023). Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease. Trials. 24(1). 603–603. 2 indexed citations

12.

Power‐Hays, Alexandra, Ruth Namazzi, Charles Drago Kato, et al.. (2023). Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial. Blood. 142(Supplement 1). 1156–1156. 1 indexed citations

13.

Ambrose, Emmanuela E., Teresa Latham, Adam Lane, et al.. (2023). Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial. The Lancet Haematology. 10(4). e261–e271. 18 indexed citations

14.

Aygün, Banu, Adam Lane, Luke R. Smart, et al.. (2023). Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience. Blood. 142(Supplement 1). 6–6. 1 indexed citations

15.

Smart, Luke R., Emmanuela E. Ambrose, Thad A. Howard, et al.. (2022). Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa. Acta Haematologica. 146(2). 95–105. 6 indexed citations

16.

Nieves, Rosa M., Teresa Latham, Sheena W. Chen, et al.. (2022). Hydroxyurea with Dose Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Dominican Republic: The Sacred Trial. Blood. 140(Supplement 1). 451–452. 1 indexed citations

17.

Nieves, Rosa M., Teresa Latham, Susan E. Stuber, et al.. (2018). Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial. Blood Advances. 2(Supplement_1). 50–53. 6 indexed citations

18.

Tshilolo, Léon, George Tomlinson, Thomas N. Williams, et al.. (2018). Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa. New England Journal of Medicine. 380(2). 121–131. 201 indexed citations

19.

Stuber, Susan E., et al.. (2017). Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia. JMIR Research Protocols. 6(6). e107–e107. 7 indexed citations

20.

Rankine‐Mullings, Angela, Marvin Reid, Jennifer Knight‐Madden, et al.. (2016). EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia. JMIR Research Protocols. 5(3). e185–e185. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact